SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AAIC, VRTV, FRGI, AEL
August 07, 2023 17:00 ET
|
Monteverde & Associates PC
NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – CIR, AAIC, QUOT, PRDS
July 24, 2023 19:55 ET
|
Monteverde & Associates PC
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – PRDS, AAIC, WMC, IMNM
July 17, 2023 17:17 ET
|
Monteverde & Associates PC
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease
July 17, 2023 07:00 ET
|
Athira Pharma, Inc.
New preclinical data demonstrate neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity In preclinical models, ATH-1105 protects against pathologies common to amyotrophic...
DAVOS ALZHEIMER’S COLLABORATIVE SHARES ADVANCEMENT OF PREPARING HEALTHCARE SYSTEMS AND INCLUSIVE RESEARCH AT THE 2023 AAIC
July 12, 2023 19:15 ET
|
Davos Alzheimer's Collaborative
New York, NY, July 12, 2023 (GLOBE NEWSWIRE) -- DAC Healthcare System Preparedness poster presentations geared for timely detection from mobilizing community workers, adding pharmacies to the...
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AAIC, NEX, KDNY, WTT
July 10, 2023 21:28 ET
|
Monteverde & Associates PC
NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
AC Immune Showcasing Precision Medicine Programs at AAIC 2023
July 03, 2023 07:00 ET
|
AC Immune SA
AC Immune Showcasing Precision Medicine Programs at AAIC 2023 Lausanne, Switzerland, July 3, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – SYNH, AAIC, PRTK, NEX
June 28, 2023 22:35 ET
|
Monteverde & Associates PC
NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – PRTK, NEX, SYNH, AAIC
June 21, 2023 19:40 ET
|
Monteverde & Associates PC
NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – FRG, SYNH, DM, AAIC
June 14, 2023 17:21 ET
|
Monteverde & Associates PC
NEW YORK, June 14, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...